November 03, 2017

ACR Officials to Address 2018 CRCPD Annual Meeting

The American College of Radiology (ACR) will play a prominent role at next year’s 50th Anniversary annual meeting of the Conference of Radiation Control Program Directors (CRCPD).

At this week’s board meeting, the CRCPD selected the Priscilla Butler, ACR senior director of quality and safety, for a presentation at the annual meeting on the ACR’s new diagnostic reference levels. The ACR will also sponsor a medical physicist member of the College to speak on implementing diagnostic reference levels in clinical practice.

The CRCPD board meeting was hosted by American Society for Radiation Oncology (ASTRO) and attended by Eugenia Brandt, ACR director of state government affairs. The annual meeting will be held May 21–24, 2018, in Charleston, SC.

Turning to other issues, the CRCPD board and stakeholders discussed the potential impact of the Food and Drug Administration’s use of International Electrotechnical Commission (IEC) standards for measuring the performance of new X-ray equipment manufacturing.

The ACR submitted comments last year in response to the FDA’s draft guidance, “Medical X-Ray Imaging Devices: Conformance with IEC Standards.” The draft comments urge transparency and public accountability because the FDA draft guidance would allow closed, proprietary IEC standards to stand in as an alternative to the agency’s corresponding performance standards, which are codified in regulation and thus maintained in accordance with U.S. administrative law. The ACR recommended that FDA adhere to a White House/Office of Management and Budget (OMB) guidance for federal agencies to ensure voluntary standards are “reasonably available” to all stakeholders before they can be incorporated into federal regulation or guidance.

Also, this week, CRCPD Executive Director Ruth McBurney, Board Chair David Allard and board members visited the ACR, other specialty medical societies and various federal agencies in Washington, DC, to discuss research initiatives, white paper development, proposed guidance and other regulatory topics.